11:04 AM EDT, 05/19/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 0.43% to 1,439.75 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biotech firm BioNTech (BNTX), which rose 3.8% and 3.7%, respectively. They were followed by furniture manufacturer Natuzzi (NTZ) and pharmaceutical company Novo Nordisk ( NVO ) , which were up 2.3% and 2%, respectively.

The decliners from continental Europe were led by biotech firm Evaxion ( EVAX ) and medical device maker EDAP TMS ( EDAP ) , which fell 6.3% and 3.4%, respectively. They were followed by biopharmaceutical companies DBV Technologies ( DBVT ) and Cellectis ( CLLS ) , which were down 2.9% and 2.5%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA) and biotech firm Autolus Therapeutics ( AUTL ) , which advanced 10% and 4.1%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and financial services company Lloyds Banking Group ( LYG ) , which increased 2.6% and 2.1%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and software company Endava ( DAVA ) , which dropped 4.4% and 3.3%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and oil and gas company BP (BP), which lost 2.2% and 1.2%, respectively.